e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Cyclerion Therapeutics, Inc. - Common Stock (NQ:CYCN)

1.950 +0.570 (+41.30%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cyclerion Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 22, 2022

It's time to start the day with an overview of the biggest pre-market stock movers traders need to know about for Tuesday morning!

Via InvestorPlace

Cyclerion Concludes Unsolicited Proposal Is Not in The Best Interest of The Company

November 22, 2022

From Cyclerion Therapeutics, Inc.

Via GlobeNewswire

Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket ↗

November 22, 2022

Gainers ObsEva SA (NASDAQ: OBSV) shares rose 71.9% to $0.2848 in pre-market trading after the company reported the sale of Ebopiprant license agreement to XOMA for up to $113 million.

Via Benzinga

Cyclerion Shares Fall After Reprioritized Pipeline, Workforce Reduction ↗

October 06, 2022

Via Benzinga

Cyclerion Neurology Candidate Shows Encouraging Action In Preclinical Studies ↗

June 17, 2022

Via Benzinga

Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday ↗

October 28, 2022

Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also...

Via Benzinga

Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday ↗

October 25, 2022

Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 17, 2022

Gainers Cyclerion Therapeutics (NASDAQ:CYCN) shares increased by 10.8% to $0.39 during Monday's after-market session. The market value of their outstanding shares is at $16.8 million.

Via Benzinga

Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session ↗

October 24, 2022

Gainers Vaxcyte, Inc. (NASDAQ: PCVX) shares jumped 65% to $33.96 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety,...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 11, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 10, 2022

Gainers

Via Benzinga

Why Avenue Therapeutics Is Trading Lower By 59%; Here Are 31 Stocks Moving Premarket ↗

October 07, 2022

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares rose 42.3% to $11.36 in pre-market trading after jumping 83% on Thursday.

Via Benzinga

Dow Dips Over 300 Points; Provention Bio Shares Spike Higher ↗

October 06, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 300 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 06, 2022

Gainers

Via Benzinga

Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday ↗

October 07, 2022

Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.

Via Benzinga

Why Cyclerion Therapeutics Stock Is Getting Hammered ↗

October 06, 2022

Cyclerion Therapeutics Inc (NASDAQ: CYCN) shares are trading lower by 43.33% to $0.53 during Thursday's trading session after the company announced a mitochondrial disease-focused strategy. The plan...

Via Benzinga

Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

October 06, 2022

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...

Via Benzinga

Nasdaq Edges Higher; AngioDynamics Shares Plummet ↗

October 06, 2022

U.S. stocks pared losses midway through trading, with the Nasdaq Composite turning higher on Thursday.

Via Benzinga

Cyclerion Announces Mitochondrial Disease-Focused Corporate Strategy

October 06, 2022

From Cyclerion Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 13, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 01, 2022

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End of The Day Summary ↗

July 28, 2022

Via Benzinga

Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate ↗

July 28, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday ↗

August 09, 2022

Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.

Via Benzinga

Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday ↗

August 02, 2022

Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.

Via Benzinga

Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in Patients with Cognitive Impairment Associated with Schizophrenia (CIAS)

July 28, 2022

From Cyclerion Therapeutics, Inc.

Via GlobeNewswire

Steven E. Hyman, M.D., Appointed to Cyclerion Therapeutics’ Board of Directors

July 26, 2022

Renowned neuroscience leader to further long-term clinical research strategy and external collaborations

From Cyclerion Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 08, 2022

Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 24, 2022

Via Benzinga

93 Biggest Movers From Yesterday ↗

June 14, 2022

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy